MIF and type 2 diabetes mellitus: In the T2DM dataset, the global signal intensity mapping reveals a notable increase in granulocyte signal output activity in the diseased state, particularly in pathways including CXCL, ADGRE5, PECAM1, and MIF (Figure 3A).